Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.constronicsinfra.com | |
Market Cap | 38.89 Cr. | |
Enterprise Value(EV) | 40.39 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.03 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 66.45 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 0.46 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 117.67 | Calculated using Price: 53.95 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.72 Cr. | 7,209,041 Shares |
FaceValue | 10 | |
About Constronics Infra Ltd. | ||
Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments. |
1 Day |
|
-2.00% |
1 Week |
|
+11.56% |
1 Month |
|
+14.49% |
3 Month |
|
+144.89% |
6 Month |
|
+357.20% |
1 Year |
|
+843.18% |
2 Year |
|
+681.88% |
5 Year |
|
+1098.89% |
10 Year |
|
+1283.33% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -10.77 | -12.17 | -14.42 | -42.43 | -171.88 | 192.41 | -138.79 | 167.27 | 25.7 | |
Return on Capital Employed (%) | -10.74 | -12.13 | -14.1 | -20.15 | -2.97 | 11.11 | -9.14 | 11.22 | 9.94 | |
Return on Assets (%) | -5.95 | -6.02 | -6.25 | -11.92 | -2.4 | 8.89 | -8.66 | 17.4 | 5.29 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Non Curr. Liab. | 1 | 0 | 0 | 1 | 1 | 1 | 1 | ||||
Curr. Liab. | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Non Curr. Assets | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |
Curr. Assets | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 1 | 2 | 2 | 2 | 1 | 0 | |||||
Other Income | 0 | 0 | 0 | 0 | 0 | ||||||
Total Income | 0 | 1 | 2 | 2 | 2 | 1 | 0 | ||||
Total Expenditure | 0 | 0 | 0 | 0 | -1 | -2 | -2 | -2 | -1 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | ||||||||
Depreciation | 0 | 0 | 0 | ||||||||
Taxation | 0 | 0 | 0 | ||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Cash Fr. Inv. | 0 | 1 | |||||||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | ||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 1 |
Thu, 02 May 2024
Shareholder Information - Receipt Of In-Principal Approval Granted By The Stock Exchange For Issue Of Upto 61 20 000 (Sixty One Lakhs Twenty Thousands) Fully Paid Up Equity Shares To Non-Promoters On A Preferential Basis Receipt of In Principal approval granted by the Stock Exchange for issue of up to 61 20 000 fully paidup equity shares to non promoters on a preferential basis |
Wed, 24 Apr 2024
Compliance Certificate - Regulation 40(10) Of SEBI (LODR) Regulation 2015 Compliance certificate - Regulation 40(10) of SEBI (LODR) Regulation 2015 |
Thu, 18 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance certificate under Reg 74(5) of SEBI(DP) Regulation 2018 |
Thu, 02 May 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Making Higher Highs for 3 days |
Close Within 52 Week High Zone |